BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28752514)

  • 1. The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen-deprivation therapy in high-risk prostate cancer following radical prostatectomy.
    Sun G; Huang R; Zhang X; Shen P; Gong J; Zhao J; Liu J; Tang Q; Shu K; Yin X; Chen N; Zeng H
    Prostate; 2017 Sep; 77(12):1279-1287. PubMed ID: 28752514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy.
    Kang M; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
    Ann Surg Oncol; 2016 Aug; 23(8):2699-706. PubMed ID: 26965702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
    Maru N; Ohori M; Kattan MW; Scardino PT; Wheeler TM
    Hum Pathol; 2001 Aug; 32(8):828-33. PubMed ID: 11521227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.
    Peng LC; Narang AK; Gergis C; Radwan NA; Han P; Marciscano AE; Robertson SP; He P; Trieu J; Ram AN; McNutt TR; Griffith E; DeWeese TA; Honig S; Singh H; Greco SC; Tran PT; Deville C; DeWeese TL; Song DY
    Urol Oncol; 2018 Jun; 36(6):309.e7-309.e14. PubMed ID: 29551548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perineural invasion as an independent predictor of biochemical recurrence in prostate cancer following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.
    Zhang LJ; Wu B; Zha ZL; Qu W; Zhao H; Yuan J; Feng YJ
    BMC Urol; 2018 Feb; 18(1):5. PubMed ID: 29390991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy.
    Katz B; Srougi M; Dall'Oglio M; Nesrallah AJ; Sant'anna AC; Pontes J; Antunes AA; Reis ST; Viana N; Sañudo A; Camara-Lopes LH; Leite KR
    Urol Oncol; 2013 Feb; 31(2):175-9. PubMed ID: 21795075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence.
    Wu S; Xie L; Lin SX; Wirth GJ; Lu M; Zhang Y; Blute ML; Dahl DM; Wu CL
    Hum Pathol; 2020 Oct; 104():96-104. PubMed ID: 32673683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.
    Ristau BT; Tomaszewski JJ; Chen YF; Bertolet M; Woldemichael E; Nelson JB
    World J Urol; 2015 Sep; 33(9):1269-74. PubMed ID: 25366883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy.
    Pagano MJ; Whalen MJ; Paulucci DJ; Reddy BN; Matulay JT; Rothberg M; Scarberry K; Patel T; Shapiro EY; RoyChoudhury A; McKiernan J; Benson MC; Badani KK
    Prostate; 2016 Feb; 76(2):226-34. PubMed ID: 26481325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural invasion as predictor of biochemical recurrence in prostate cancer following open radical prostatectomy: a single-center experience.
    Stankovic M; Wolff L; Wieder T; Mendes J; Schumacher B
    World J Urol; 2022 Nov; 40(11):2695-2700. PubMed ID: 36153466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
    Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
    J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy.
    Matsumoto K; Niwa N; Hagiwara M; Kosaka T; Takeda T; Yasumizu Y; Tanaka N; Morita S; Mizuno R; Shinojima T; Hara S; Asanuma H; Oya M
    Int J Clin Oncol; 2021 Apr; 26(4):744-752. PubMed ID: 33387085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy.
    Lian Z; Zhang H; He Z; Ma S; Wang X; Liu R
    World J Surg Oncol; 2020 Aug; 18(1):201. PubMed ID: 32791998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.
    Mauermann J; Fradet V; Lacombe L; Dujardin T; Tiguert R; Tetu B; Fradet Y
    Eur Urol; 2013 Jul; 64(1):19-25. PubMed ID: 22901983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.
    Messing EM; Manola J; Yao J; Kiernan M; Crawford D; Wilding G; di'SantAgnese PA; Trump D;
    Lancet Oncol; 2006 Jun; 7(6):472-9. PubMed ID: 16750497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer.
    McKay RR; Gray KP; Hayes JH; Bubley GJ; Rosenberg JE; Hussain A; Kantoff PW; Taplin ME
    Cancer; 2015 Aug; 121(15):2603-11. PubMed ID: 25903013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
    Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
    Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?
    Loeb S; Epstein JI; Humphreys EB; Walsh PC
    BJU Int; 2010 Jun; 105(11):1510-3. PubMed ID: 19694710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.